Home LiteratureArticle Details
PMID: 22281707 Published · ppublish English Journal Article Review

Cystinuria: mechanisms and management.

Pediatric nephrology (Berlin, Germany) ·Vol. 27 ·No. 11 ·2012-11-00 ·Pages 2031-2038

Claes DJ, Jackson E

Abstract

Cystinuria is a relatively uncommon cause of pediatric stone disease, but has significant morbidity if not properly controlled because of its significant stone recurrence rate. Cystinuria is caused by the inability of the renal tubules to reabsorb filtered cystine, which is poorly soluble at a typical urine pH <7. Although many advances have been made in the understanding of the genetic and physiological basis of cystinuria, the cornerstones of treatment still involve stone prevention with dietary measures and pharmacological therapy, coupled with surgical interventions for stone removal. Pharmacological treatments can carry significant side effects that must be monitored and can limit therapy as well as impede compliance. Most patients will require surgical intervention for stone removal, although compliance with prevention strategies reduces the need for intervention.

MeSH Terms
Absorption Animals Cystine/chemistry,metabolism Cystinuria/diagnosis,etiology,genetics,physiopathology,therapy,urine Diet, Protein-Restricted Diet, Sodium-Restricted Genetic Predisposition to Disease Humans Hydrogen-Ion Concentration Kidney Tubules/metabolism,physiopathology Nephrolithiasis/diagnosis,etiology,genetics,physiopathology,therapy,urine Patient Compliance Phenotype Potassium Citrate/therapeutic use Sodium Bicarbonate/therapeutic use Solubility Sulfhydryl Compounds/therapeutic use Treatment Outcome Urologic Surgical Procedures
Chemicals
Sulfhydryl Compounds Cystine Sodium Bicarbonate Potassium Citrate
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Claes Donna J
Division of Pediatric Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, USA. [email protected].
Jackson Elizabeth
Division of Pediatric Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, USA.
References (36)
36 references, click to expand
  1. Renal crystal deposits and histopathology in patients with cystine stones.
    Kidney Int. 2006 Jun;69(12):2227-35 PMID: 16710357
  2. Clinical use of cystine supersaturation measurements.
    J Urol. 2000 Nov;164(5):1481-5 PMID: 11025687
  3. Durability of the medical management of cystinuria.
    J Urol. 2003 Jan;169(1):68-70 PMID: 12478105
  4. Penicillamine therapy for pediatric cystinuria: experience from a cohort of American children.
    J Urol. 2008 Dec;180(6):2620-3 PMID: 18951580
  5. Effect of penicillamine (a vitamin B6 antagonist) on pyridoxal enzymes.
    J Biochem. 1973 Sep;74(3):587-92 PMID: 4148378
  6. Three pathways for human kidney stone formation.
    Urol Res. 2010 Jun;38(3):147-60 PMID: 20411383
  7. Medical treatment of cystinuria: critical reappraisal of long-term results.
    J Urol. 2000 May;163(5):1419-23 PMID: 10751848
  8. Cystine calculi: correlation of CT-visible structure, CT number, and stone morphology with fragmentation by shock wave lithotripsy.
    Urol Res. 2007 Dec;35(6):319-24 PMID: 17965956
  9. The molecular basis of cystinuria.
    Nephron Exp Nephrol. 2004;98(2):e45-9 PMID: 15499206
  10. Aminoacidurias: Clinical and molecular aspects.
    Kidney Int. 2008 Apr;73(8):918-25 PMID: 18200002
  11. Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up.
    Pediatr Nephrol. 2005 Jan;20(1):19-24 PMID: 15602663
  12. Extracorporeal shock wave lithotripsy in prepubertal children: 22-year experience at a single institution with a single lithotriptor.
    J Urol. 2009 Oct;182(4 Suppl):1835-9 PMID: 19692011
  13. New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype.
    J Med Genet. 2005 Jan;42(1):58-68 PMID: 15635077
  14. Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification.
    J Am Soc Nephrol. 2002 Oct;13(10):2547-53 PMID: 12239244
  15. Crystal growth inhibitors for the prevention of L-cystine kidney stones through molecular design.
    Science. 2010 Oct 15;330(6002):337-341 PMID: 20947757
  16. Evaluation of cystine transport in cultured human kidney cells and establishment of cystinuria type I phenotype by antisense technology.
    Urol Res. 2008 Feb;36(1):25-9 PMID: 18074125
  17. Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugs.
    J Urol. 2001 Aug;166(2):688-93 PMID: 11458118
  18. Management of cystinuric patients: an observational, retrospective, single-centre analysis.
    Urol Int. 2008;80(2):141-4 PMID: 18362482
  19. Management of cystinuria.
    Urol Clin North Am. 2007 Aug;34(3):347-62 PMID: 17678985
  20. Adverse effects profile of sulfhydryl compounds in man.
    Am J Med. 1986 Mar;80(3):471-6 PMID: 2937293
  21. Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate.
    Urology. 2008 Aug;72(2):278-81 PMID: 18533229
  22. Chronic kidney disease in kidney stone formers.
    Clin J Am Soc Nephrol. 2011 Aug;6(8):2069-75 PMID: 21784825
  23. New horizons in the management of patients with cystinuria.
    Curr Opin Urol. 2010 Mar;20(2):169-73 PMID: 19887942
  24. Captopril reduces urinary cystine excretion in cystinuria.
    Arch Intern Med. 1987 Aug;147(8):1409-12 PMID: 2820331
  25. Cystinuria.
    Acta Paediatr Suppl. 2006 Jul;95(452):31-3 PMID: 16801163
  26. Cystinuria in children and young adults: success of monitoring free-cystine urine levels.
    Pediatr Nephrol. 2007 Nov;22(11):1869-73 PMID: 17694338
  27. The effect of penicillamine on vitamin B6 function in man.
    Biochem Pharmacol. 1981 Nov 15;30(22):3051-3 PMID: 7337722
  28. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis.
    BJU Int. 2006 Jun;97(6):1285-90 PMID: 16686727
  29. Cystinuria.
    Semin Nephrol. 2008 Mar;28(2):181-91 PMID: 18359399
  30. Kidney stones and the risk for chronic kidney disease.
    Clin J Am Soc Nephrol. 2009 Apr;4(4):804-11 PMID: 19339425
  31. Multi-system disorder syndromes associated with cystinuria type I.
    Curr Mol Med. 2008 Sep;8(6):544-50 PMID: 18781961
  32. Identification of novel cystinuria mutations in pediatric patients.
    J Pediatr Urol. 2006 Dec;2(6):575-8 PMID: 18947684
  33. The amino acid transport system b(o,+) and cystinuria.
    Mol Membr Biol. 2001 Jan-Mar;18(1):21-6 PMID: 11396607
  34. The impact of cystinuria on renal function.
    J Urol. 2002 Jul;168(1):27-30 PMID: 12050485
  35. Cystine: a promoter of the growth and aggregation of calcium oxalate crystals in normal undiluted human urine.
    J Urol. 2002 Jan;167(1):317-21 PMID: 11743349
  36. Cystinuria in children: distribution and frequencies of mutations in the SLC3A1 and SLC7A9 genes.
    Kidney Int. 2002 Oct;62(4):1136-42 PMID: 12234283
Article Info
Journal
Pediatric nephrology (Berlin, Germany)
Abbr.
Pediatr Nephrol
ISSN
1432-198X
Published
2012-11-00
Epub
2012-00-27
Pages
2031-2038
Language
English
Region
Germany
NLM ID
8708728
Subset
IM
Grants
NCATS NIH HHS · UL1 TR000077 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]